IBDEI0RK ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12409,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12409,1,3,0)
;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antibodies/Inhibitors
;;^UTILITY(U,$J,358.3,12409,1,4,0)
;;=4^D68.318
;;^UTILITY(U,$J,358.3,12409,2)
;;=^340504
;;^UTILITY(U,$J,358.3,12410,0)
;;=D50.9^^49^600^30
;;^UTILITY(U,$J,358.3,12410,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12410,1,3,0)
;;=3^Iron Deficiency Anemia,Unspec
;;^UTILITY(U,$J,358.3,12410,1,4,0)
;;=4^D50.9
;;^UTILITY(U,$J,358.3,12410,2)
;;=^5002283
;;^UTILITY(U,$J,358.3,12411,0)
;;=D64.81^^49^600^3
;;^UTILITY(U,$J,358.3,12411,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12411,1,3,0)
;;=3^Anemia d/t Antineoplastic Chemotherapy
;;^UTILITY(U,$J,358.3,12411,1,4,0)
;;=4^D64.81
;;^UTILITY(U,$J,358.3,12411,2)
;;=^5002349
;;^UTILITY(U,$J,358.3,12412,0)
;;=D63.1^^49^600^5
;;^UTILITY(U,$J,358.3,12412,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12412,1,3,0)
;;=3^Anemia in Chronic Kidney Disease
;;^UTILITY(U,$J,358.3,12412,1,4,0)
;;=4^D63.1
;;^UTILITY(U,$J,358.3,12412,2)
;;=^332908
;;^UTILITY(U,$J,358.3,12413,0)
;;=D62.^^49^600^1
;;^UTILITY(U,$J,358.3,12413,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12413,1,3,0)
;;=3^Acute Blood Loss Anemia
;;^UTILITY(U,$J,358.3,12413,1,4,0)
;;=4^D62.
;;^UTILITY(U,$J,358.3,12413,2)
;;=^267986
;;^UTILITY(U,$J,358.3,12414,0)
;;=D51.9^^49^600^36
;;^UTILITY(U,$J,358.3,12414,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12414,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia,Unspec
;;^UTILITY(U,$J,358.3,12414,1,4,0)
;;=4^D51.9
;;^UTILITY(U,$J,358.3,12414,2)
;;=^5002289
;;^UTILITY(U,$J,358.3,12415,0)
;;=D51.3^^49^600^35
;;^UTILITY(U,$J,358.3,12415,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12415,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia,Dietary
;;^UTILITY(U,$J,358.3,12415,1,4,0)
;;=4^D51.3
;;^UTILITY(U,$J,358.3,12415,2)
;;=^5002287
;;^UTILITY(U,$J,358.3,12416,0)
;;=D51.0^^49^600^32
;;^UTILITY(U,$J,358.3,12416,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12416,1,3,0)
;;=3^Pernicious Anemia
;;^UTILITY(U,$J,358.3,12416,1,4,0)
;;=4^D51.0
;;^UTILITY(U,$J,358.3,12416,2)
;;=^5002284
;;^UTILITY(U,$J,358.3,12417,0)
;;=D50.0^^49^600^4
;;^UTILITY(U,$J,358.3,12417,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12417,1,3,0)
;;=3^Anemia d/t Blood Loss (Chronic)
;;^UTILITY(U,$J,358.3,12417,1,4,0)
;;=4^D50.0
;;^UTILITY(U,$J,358.3,12417,2)
;;=^267971
;;^UTILITY(U,$J,358.3,12418,0)
;;=E11.21^^49^600^19
;;^UTILITY(U,$J,358.3,12418,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12418,1,3,0)
;;=3^DM Type 2 w/ Nephropathy
;;^UTILITY(U,$J,358.3,12418,1,4,0)
;;=4^E11.21
;;^UTILITY(U,$J,358.3,12418,2)
;;=^5002629
;;^UTILITY(U,$J,358.3,12419,0)
;;=E11.22^^49^600^9
;;^UTILITY(U,$J,358.3,12419,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12419,1,3,0)
;;=3^DM Type 2 w/ Diabetic CKD
;;^UTILITY(U,$J,358.3,12419,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,12419,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,12420,0)
;;=E11.29^^49^600^20
;;^UTILITY(U,$J,358.3,12420,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12420,1,3,0)
;;=3^DM Type 2 w/ Other Diabetic Kidney Complication
;;^UTILITY(U,$J,358.3,12420,1,4,0)
;;=4^E11.29
;;^UTILITY(U,$J,358.3,12420,2)
;;=^5002631
;;^UTILITY(U,$J,358.3,12421,0)
;;=E11.311^^49^600^21
;;^UTILITY(U,$J,358.3,12421,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12421,1,3,0)
;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/ Macular edema
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0RK 3831 printed Apr 09, 2024@21:26:41 Page 2
IBDEI0RK ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12409,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,12409,1,3,0)
+4 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antibodies/Inhibitors
+5 ;;^UTILITY(U,$J,358.3,12409,1,4,0)
+6 ;;=4^D68.318
+7 ;;^UTILITY(U,$J,358.3,12409,2)
+8 ;;=^340504
+9 ;;^UTILITY(U,$J,358.3,12410,0)
+10 ;;=D50.9^^49^600^30
+11 ;;^UTILITY(U,$J,358.3,12410,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,12410,1,3,0)
+14 ;;=3^Iron Deficiency Anemia,Unspec
+15 ;;^UTILITY(U,$J,358.3,12410,1,4,0)
+16 ;;=4^D50.9
+17 ;;^UTILITY(U,$J,358.3,12410,2)
+18 ;;=^5002283
+19 ;;^UTILITY(U,$J,358.3,12411,0)
+20 ;;=D64.81^^49^600^3
+21 ;;^UTILITY(U,$J,358.3,12411,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,12411,1,3,0)
+24 ;;=3^Anemia d/t Antineoplastic Chemotherapy
+25 ;;^UTILITY(U,$J,358.3,12411,1,4,0)
+26 ;;=4^D64.81
+27 ;;^UTILITY(U,$J,358.3,12411,2)
+28 ;;=^5002349
+29 ;;^UTILITY(U,$J,358.3,12412,0)
+30 ;;=D63.1^^49^600^5
+31 ;;^UTILITY(U,$J,358.3,12412,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,12412,1,3,0)
+34 ;;=3^Anemia in Chronic Kidney Disease
+35 ;;^UTILITY(U,$J,358.3,12412,1,4,0)
+36 ;;=4^D63.1
+37 ;;^UTILITY(U,$J,358.3,12412,2)
+38 ;;=^332908
+39 ;;^UTILITY(U,$J,358.3,12413,0)
+40 ;;=D62.^^49^600^1
+41 ;;^UTILITY(U,$J,358.3,12413,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,12413,1,3,0)
+44 ;;=3^Acute Blood Loss Anemia
+45 ;;^UTILITY(U,$J,358.3,12413,1,4,0)
+46 ;;=4^D62.
+47 ;;^UTILITY(U,$J,358.3,12413,2)
+48 ;;=^267986
+49 ;;^UTILITY(U,$J,358.3,12414,0)
+50 ;;=D51.9^^49^600^36
+51 ;;^UTILITY(U,$J,358.3,12414,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,12414,1,3,0)
+54 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
+55 ;;^UTILITY(U,$J,358.3,12414,1,4,0)
+56 ;;=4^D51.9
+57 ;;^UTILITY(U,$J,358.3,12414,2)
+58 ;;=^5002289
+59 ;;^UTILITY(U,$J,358.3,12415,0)
+60 ;;=D51.3^^49^600^35
+61 ;;^UTILITY(U,$J,358.3,12415,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,12415,1,3,0)
+64 ;;=3^Vitamin B12 Deficiency Anemia,Dietary
+65 ;;^UTILITY(U,$J,358.3,12415,1,4,0)
+66 ;;=4^D51.3
+67 ;;^UTILITY(U,$J,358.3,12415,2)
+68 ;;=^5002287
+69 ;;^UTILITY(U,$J,358.3,12416,0)
+70 ;;=D51.0^^49^600^32
+71 ;;^UTILITY(U,$J,358.3,12416,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,12416,1,3,0)
+74 ;;=3^Pernicious Anemia
+75 ;;^UTILITY(U,$J,358.3,12416,1,4,0)
+76 ;;=4^D51.0
+77 ;;^UTILITY(U,$J,358.3,12416,2)
+78 ;;=^5002284
+79 ;;^UTILITY(U,$J,358.3,12417,0)
+80 ;;=D50.0^^49^600^4
+81 ;;^UTILITY(U,$J,358.3,12417,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,12417,1,3,0)
+84 ;;=3^Anemia d/t Blood Loss (Chronic)
+85 ;;^UTILITY(U,$J,358.3,12417,1,4,0)
+86 ;;=4^D50.0
+87 ;;^UTILITY(U,$J,358.3,12417,2)
+88 ;;=^267971
+89 ;;^UTILITY(U,$J,358.3,12418,0)
+90 ;;=E11.21^^49^600^19
+91 ;;^UTILITY(U,$J,358.3,12418,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,12418,1,3,0)
+94 ;;=3^DM Type 2 w/ Nephropathy
+95 ;;^UTILITY(U,$J,358.3,12418,1,4,0)
+96 ;;=4^E11.21
+97 ;;^UTILITY(U,$J,358.3,12418,2)
+98 ;;=^5002629
+99 ;;^UTILITY(U,$J,358.3,12419,0)
+100 ;;=E11.22^^49^600^9
+101 ;;^UTILITY(U,$J,358.3,12419,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,12419,1,3,0)
+104 ;;=3^DM Type 2 w/ Diabetic CKD
+105 ;;^UTILITY(U,$J,358.3,12419,1,4,0)
+106 ;;=4^E11.22
+107 ;;^UTILITY(U,$J,358.3,12419,2)
+108 ;;=^5002630
+109 ;;^UTILITY(U,$J,358.3,12420,0)
+110 ;;=E11.29^^49^600^20
+111 ;;^UTILITY(U,$J,358.3,12420,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,12420,1,3,0)
+114 ;;=3^DM Type 2 w/ Other Diabetic Kidney Complication
+115 ;;^UTILITY(U,$J,358.3,12420,1,4,0)
+116 ;;=4^E11.29
+117 ;;^UTILITY(U,$J,358.3,12420,2)
+118 ;;=^5002631
+119 ;;^UTILITY(U,$J,358.3,12421,0)
+120 ;;=E11.311^^49^600^21
+121 ;;^UTILITY(U,$J,358.3,12421,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,12421,1,3,0)
+124 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/ Macular edema
